Svas Biosana S.p.A. (BIT:SVS)
Italy · Delayed Price · Currency is EUR 9.00
0.00 (0.00%)
Last updated: Apr 16, 2026, 5:29 PM CET
Svas Biosana Market Cap
Svas Biosana has a market cap or net worth of €47.82 million as of April 16, 2026. Its market cap has increased by 27.47% in one year.
Market Cap
47.82M
Enterprise Value
92.75M
Revenue
134.95M
Ranking
n/a
PE Ratio
7.09
Stock Price
€9.00
Market Cap Chart
Since December 9, 2021, Svas Biosana's market cap has decreased from 81.14M to 47.82M, a decrease of -41.07%. That is a compound annual growth rate of -11.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 47.82M | 12.50% |
| Dec 30, 2025 | 42.51M | 10.91% |
| Dec 30, 2024 | 38.33M | -11.25% |
| Dec 29, 2023 | 43.19M | -20.87% |
| Dec 30, 2022 | 54.58M | -37.13% |
| Dec 30, 2021 | 86.80M | 6.97% |
| Dec 9, 2021 | 81.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 10.22B |
| DiaSorin | 3.35B |
| Amplifon | 2.07B |
| EL.En. | 1.06B |
| GPI S.p.A. | 472.62M |
| Garofalo Health Care | 406.33M |
| Talea Group | 40.74M |
| Arterra Bioscience | 20.24M |